Adoption of Biosimilars: Prescribers, Pharmacy and Payer Perspectives

This activity is supported by an educational grant from Merck Sharp & Dohme, and Amgen.

Adoption of Biosimilars: Prescribers, Pharmacy and Payer Perspectives


Steven D. Lucio, PharmD, BCPS

Senior Director

Clinical Solutions and Pharmacy Program Development


Irving, Texas

Editorial Support

Debra Gordon, MS


GordonSquared, Inc

Highland Park, Illinois

Educational Objectives

At completion of this activity, the participant will be able to:

  • Explain the development and approval process for biosimilars
  • Identify how biosimilars differ from small-molecule generics
  • Examine the challenges to clinicians in adopting biosimilars in clinical practice
  • Illustrate potential barriers to physician and patient uptake of biosimilars
  • Determine how formulary and clinical adoption of biosimilar agents will impact managed care

Pharmacists and managed care professionals.

Target Audience:


Type of activity:

April 12, 2016

Release date:

April 12, 2017

Expiration date:

1.5 hours

Estimated time to complete activity:



Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-16-048-H01-P. The activity is available for CE credit through April 12, 2017.

Instructions for Completing the Activity and Receiving CPE Credit

Participants must read the article in its entirety, complete the online pre-test, post-test and activity evaluation to receive credit. A passing score of 70% is required on the post-test. Participants receiving a failing grade on the post-test will be permitted to retake it at no cost. After successful completion of the online post-test and activity evaluation, your credit will be uploaded to CPE Monitor

. You may view your credit within 48 hours at


Your CE credit will be automatically uploaded to CPE Monitor

. Please ensure that your Pharmacy Times account is updated with your NABP e-profile ID number and your date of birth. Participation data will not be uploaded into CPE Monitor

if you do not have your NABP e-profile ID number and date of birth entered into your profile on




, has the following relevant financial relationships with commercial interests to disclose.

Steven Lucio, PharmD, BCPS

  • Employment: Vizient

The following contributors have no relevant financial relationships with commercial interests to disclose


Debra Gordon, MS

Pharmacy Times Continuing Education

—David Heckard; Maryjo Dixon, RPh; Donna Fausak; Nathalie Harden; and Tara DeLorenzo

Planning staff

The American Journal of Pharmacy Benefits

— Nicole Beagin

Planning staff

An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

For Pharmacists Credit (CPE) only: Start Activity

Related Videos
Related Content
© 2023 MJH Life Sciences
All rights reserved.